Skip to main content
Monday
October 13, 2025
Sign In
Subscribe
Latest
Economy
Banking
Stocks
Industry
Analysis
Bazaar
RMG
Corporates
Aviation
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Get the Paper
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Explainer
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
MONDAY,
OCTOBER 13, 2025
Novavax Covid-19 Vaccine
Novavax Covid-19 Vaccine
US FDA authorizes Novavax Covid vaccine for adults
Novavax Covid-19 vaccine gets first authorization; expects more within weeks, CEO says
India allows Serum Institute to enrol 7-11 year olds in Novavax Covid-19 vaccine trial
Novavax begins early-stage trial for combined influenza/Covid-19 vaccine
EU seals deal with Novavax for up to 200 million Covid-19 vaccines
India might approve Novavax in 2 months, likely to cost more than Covishield: CEO
SII to introduce Novavax vaccine in India by September
Novavax vaccine efficacy data promising; trials in advanced stage: Indian govt
Novavax Covid vaccine to be made by Serum Institute, shows 90% efficacy
Novavax Covid-19 vaccine more than 90% effective in US trial
Novavax says supply shortages delaying full-speed production of its Covid-19 vaccine
Novavax starts allowing participants on placebo to get Covid-19 vaccine in trials
Novavax delays EU vaccine supply deal amid production problems - source
Show More